$315 Million is the total value of Sio Capital Management, LLC's 49 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ABC | Buy | AMERISOURCEBERGEN CORP | $38,217,000 | +47.3% | 282,399 | +54.0% | 12.14% | +24.7% |
| APLS | New | APELLIS PHARMACEUTICALS INCput | $34,676,000 | – | 507,700 | +100.0% | 11.02% | – |
| New | GSK PLCsponsored ads | $23,267,000 | – | 790,600 | +100.0% | 7.39% | – | |
| RLMD | New | RELMADA THERAPEUTICS INCput | $22,442,000 | – | 606,200 | +100.0% | 7.13% | – |
| RXDX | Buy | PROMETHEUS BIOSCIENCES INCput | $19,603,000 | +583.5% | 332,200 | +227.0% | 6.23% | +478.4% |
| OGN | Buy | ORGANON & CO | $14,715,000 | -24.2% | 628,836 | +9.4% | 4.68% | -35.8% |
| SNY | New | SANOFI SAsponsored adr | $13,569,000 | – | 356,888 | +100.0% | 4.31% | – |
| UTHR | Buy | UNITED THERAPEUTICS CORP | $9,414,000 | -0.0% | 44,959 | +12.5% | 2.99% | -15.4% |
| SKIN | Buy | THE BEAUTY HEALTH CO | $7,769,000 | +66.8% | 658,964 | +81.9% | 2.47% | +41.1% |
| SNN | New | SMITH & NEPHEW PLCspdn adr new | $5,303,000 | – | 228,390 | +100.0% | 1.68% | – |
| PNT | Buy | POINT BIOPHARMA GLOBAL INC | $4,209,000 | +22.5% | 544,545 | +7.9% | 1.34% | +3.6% |
| XFOR | Buy | X4 PHARMACEUTICALS INC | $2,426,000 | +808.6% | 1,418,461 | +412.2% | 0.77% | +671.0% |
| IDYA | New | IDEAYA BIOSCIENCES INC | $1,044,000 | – | 70,000 | +100.0% | 0.33% | – |
| CLNN | New | CLENE INC.put | $64,000 | – | 22,700 | +100.0% | 0.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VIKING THERAPEUTICS INC | 24 | Q3 2023 | 3.4% |
| UNITED THERAPEUTICS ORD | 23 | Q3 2023 | 8.3% |
| CARDINAL HEALTH ORD | 20 | Q2 2022 | 7.2% |
| SANOFI SA | 19 | Q3 2022 | 9.8% |
| MEDTRONIC PLC | 18 | Q3 2023 | 5.2% |
| CATALYST BIOSCIENCES INC | 18 | Q3 2021 | 17.8% |
| PFENEX ORD | 18 | Q4 2019 | 5.9% |
| AEGLEA BIOTHERAPEUTICS INC | 18 | Q1 2023 | 1.1% |
| HCA HEALTHCARE INC | 17 | Q2 2022 | 5.5% |
| MCKESSON ORD | 17 | Q1 2022 | 6.0% |
View Sio Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Modular Medical, Inc. | February 13, 2023 | 1,091,479 | 10.0% |
| Cellectar Biosciences, Inc. | February 10, 2022 | ? | ? |
| CURIS INC | February 10, 2022 | 3,866,645 | 4.2% |
| Salarius Pharmaceuticals, Inc. | February 10, 2022 | 1,354,291 | 3.0% |
| Larimar Therapeutics, Inc. | February 16, 2021 | 188,661 | 1.2% |
| ACHIEVE LIFE SCIENCES, INC. | February 14, 2020 | ? | ? |
| Bionano Genomics, Inc | February 14, 2020 | 1,210,821 | 4.6% |
| Brickell Biotech, Inc. | February 14, 2020 | ? | ? |
| Trillium Therapeutics Inc. | February 14, 2020 | 2,751,186 | 9.8% |
| ZAFGEN, INC. | February 14, 2020 | 2,283,164 | 6.1% |
View Sio Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2022-11-14 |
View Sio Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.